IL1B and cryopyrin-associated periodic syndrome: In addition, pharmacological inhibitors targeting HSP90β prevented the abnormal secretion of IL-1β from peripheral blood mononuclear cells (PBMCs) isolated from CAPS patients, except in cases of the most severe form of the disease.